RM-MCE / Mitochondrial and cellular-energy research
AICAR
Also known as: AICA riboside · Acadesine · AICA ribotide · ZMP
Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.
What this is
AICAR is a market acronym with two common chemical meanings. Neither is a peptide. The unphosphorylated nucleoside is acadesine; the intracellular monophosphate is AICA ribotide or ZMP.
Evidence position
The entry remains Grade U because a bare AICAR label does not resolve which structure is present.
What the record does not establish
Research on acadesine cannot authenticate an AICA-ribotide sample, and neither record validates a seller, vial or intended use.
Sources
- 01AICA ribotide compound recordPubChem
- Shows
- Phosphorylated nucleotide identity, formula and synonyms
- Does not show
- This record is not the same structure as acadesine
- 02Acadesine compound recordPubChem
- Shows
- Ribonucleoside identity for acadesine or AICA-riboside
- Does not show
- The name AICAR is used inconsistently across literature and product pages
- 03Systematic review of AICAr pharmacologyPubMed
- Shows
- Distinguishes AICA-riboside use and documents AMPK-independent effects
- Does not show
- Mechanism review; not a peptide record and not supplier-quality evidence
External database index
LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE
Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.
PUBCHEM / IDENTITY
AICA Ribotide
- CID
- 65110
- Formula
- C9H15N4O8P
- Mass
- 338.21
PUBMED / FOUND RECORDS
- AICA-riboside (acadesine), an activator of AMP-activated protein kinase with potential for application in hematologic malignancies.Expert opinion on investigational drugs / 2010 AprPMID 20367195 / DOI 10.1517/13543781003703694
- CD137L promotes immune surveillance in melanoma via HLTF regulation.Nature communications / 2025 Sep 26PMID 41006211 / DOI 10.1038/s41467-025-63338-w
- Negative pressure wound therapy improves bone regeneration by promoting osteogenic differentiation via the AMPK-ULK1-autophagy axis.Autophagy / 2022 SepPMID 34964701 / DOI 10.1080/15548627.2021.2016231
- Acadesine (AICA-riboside) improves postischemic cardiac recovery.The Annals of thoracic surgery / 1992 JulPMID 1610261 / DOI 10.1016/0003-4975(92)91148-3
- Acadesine (AICA-riboside): disposition and metabolism of an adenosine-regulating agent.Journal of clinical pharmacology / 1993 OctPMID 8227467 / DOI 10.1002/j.1552-4604.1993.tb01929.x